Anticancer Therapies – Products

The addition of this technology to the MISSION® shRNA platform pairs the benefits of lentiviral-based shRNA with a simple streamlined protocol.

Myriad's TheraGuide 5-FU™ helps predict which cancer patients are likely to suffer serious toxic reactions to chemotherapy.

The BioStation CT can provide a system for managing, observing and recording cell growth, morphology, and protein expression in culture by providing consistent environmental control of temperature, humidity and gas concentration.

eCoil designed to produce magnetic resonance images for targeted prostate cancer treatment.

iPlan RT gives clinicians the flexibility to combine complete diagnostic information with broader treatment options.

The kit improves the detection of T790M mutations on the EGFR gene.

The cell line will be valuable for the testing of chemopreventive agents and for screening cancer causing agents.

Interpretation and Implementation of Good Clinical Practice in drug trials

ActiveSight has also initiated a fragment screening program centered on targets in their Protein Portfolio product line.